Effects of treatment or covariates on Ang-2 levels in the RAVE trial.

*Values at screening. “On Treatment” = glucocorticoids or any other immune-suppressive drug.
†Values at month 6 restricted to subjects in remission. RTX = rituximab. CYC/AZA = cyclophosphamide followed by azathioprine. Only subjects who were still in their original treatment groups were included in the RTX vs. CYC/AZA analysis.
‡Values at month 6 restricted to subjects in remission.
§Numbers fulfilling and not fulfilling the criteria in column one.
¶Serum Ang-2 (ng/ml) in subjects fulfilling (Yes) and not fulfilling (No) the criteria in column one; medians and interquartile ranges are shown.